Cerenome (CNSY) vs SeaStar Medical (ICU)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
SeaStar Medical (ICU) has outperformed Cerenome (CNSY) over the past year, losing 40.2% versus a loss of 89.3%. Over five years, CNSY leads with a -99.7% price change compared with -99.9% for ICU. SeaStar Medical is the larger company by market cap ($19.0 million vs $14.6 million), about 1.3 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNSY | ICU |
|---|---|---|
| Share price | $1.93 | $3.61 |
| Market cap | $14.65M | $18.99M |
| 1-day change | +7.82% | +3.44% |
| YTD return | -84.86% | +50.42% |
| 1-year return | -89.28% | -40.23% |
| 5-year return | -99.71% | -99.86% |
| EPS (TTM) | $-3.36 | $-2.97 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $19.00 | $7.35 |
| 52-week low | $1.49 | $2.07 |
| Distance from 52-week high | -89.84% | -50.88% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +1337.82% | +177.01% |
| Average volume | 121.94K | 99.80K |
| Shares outstanding | 7.59M | 5.26M |
| Employees | 28 | 18 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ICU has outperformed CNSY by 49.0 percentage points over the past year.
About Cerenome
CNSY stock →Cerenome, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. The company's lead radiotherapeutic candidate is rhenium obisbemeda, a patented radiotherapy for patients with central nervous system and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers.
Health Care · Medical/Dental Instruments · 28 employees
About SeaStar Medical
ICU stock →SeaStar Medical Holding Corporation, a commercial-stage healthcare company, develops a proprietary platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers the selective cytopheretic device (SCD), which is a disease-modifying device that neutralizes over-active immune cells and stops the cytokine storm that yields destructive hyperinflammation; and QUELIMMUNE, an SCD therapy for pediatric patients with acute kidney injury (AKI) due to sepsis.
Health Care · Medical/Dental Instruments · 18 employees
CNSY vs ICU FAQ
Which is bigger, Cerenome or SeaStar Medical?
SeaStar Medical (ICU) is larger, with a market capitalization of $18.99M compared with $14.65M for Cerenome (CNSY).
Which stock has performed better over the past year, CNSY or ICU?
ICU returned -40.23% over the past 12 months, compared with -89.28% for CNSY (price return, excluding dividends). Past performance does not predict future results.
Are Cerenome and SeaStar Medical in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.